Fuliang Chu

3.3k citations

39 papers · 2.0k indexed · 1 hit paper · h-index 19

Impact in

Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Virology top 10%

Papers in

Immunology 23
- Immune Cell Function and Interaction 17
- T-cell and B-cell Immunology 9
- Immunotherapy and Immune Responses 8
- Galectins and Cancer Biology 3
Oncology 20
- CAR-T cell therapy research 12
- Cancer Immunotherapy and Biomarkers 10

Co-authors: Sattva S. Neelapu Chen Dong Roza Nurieva Seema Rawal Shinya Tanaka Gustavo Martínez Hoyong Lim Joseph M. Reynolds
Journals: Blood (9 papers)The Journal of Immunology (2 papers)OncoImmunology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Hematological Oncology (1 paper)
Partner nations: United States China United Kingdom

In The Last Decade

Fuliang Chu

39 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions 2011 · 877 citations

Peers

Countries citing papers authored by Fuliang Chu

Since Specialization

Citations

This map shows the geographic impact of Fuliang Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuliang Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuliang Chu more than expected).

Fields of papers citing papers by Fuliang Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuliang Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuliang Chu. The network helps show where Fuliang Chu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fuliang Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fuliang Chu Line = papers co-authored together Fuliang Chu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment Breast Cancer Research ·Shuying Liu, Laura Devon Flesor, Wenbin Liu, Mihai Gagea, Ariella B. Hanker, Nguyen Thanh Nguyen, Akshara Singareeka Raghavendra, Melissa Gilbert-Ross, Fuliang Chu, Sattva S. Neelapu, Adriano Marchese, Samir Hanash, Johann Zimmermann, Carlos L. Arteaga, Debasish Tripathy	2023	20
2	Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas Journal for ImmunoTherapy of Cancer ·Fuliang Chu, Jingjing Cao, Jingwei Liu, Haopeng Yang, Timothy J. Davis, 南学正臣, Xiaoyun Cheng, Thomas James Drakeley, Fei Gao, Long Vien, Laura Bover, Ryan Sun, Francisco Vega, Michael R. Green, R. Eric Davis, Sattva S. Neelapu	2023	9
3	Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma Blood Advances ·Loretta J. Nastoupil, Advaita Chakraborty, Jason R. Westin, Nathan Fowler, Felipe Samaniego, Xiaoyun Cheng, Man Chun John, Jaiyeoba Oluwatoyin Mercy, Fuliang Chu, Marco Gemin, I. Morgado, 晃生山下, Lei Feng, Shouhao Zhou, Michael R. Green, R. Eric Davis, Sattva S. Neelapu	2022	29
4	Versatile CAR T-cells for cancer immunotherapy Współczesna Onkologia ·Fuliang Chu, Jingjing Cao, Rodrick W. Lewis	2018	18
5	IL-15 enhances the antitumor effect of human antigen-specific CD8⁺T cells by cellular senescence delay OncoImmunology ·Jinsheng Weng, 홍준향, Vidya M.J, Fuliang Chu, Sung-Doo Kim, Jin He, Zuliang Jie, Xiaoping Xie, Wencai Ma, Jianfei Qian, Liang Zhang, Jing Yang, Qing Yi, Sattva S. Neelapu, Larry W. Kwak	2016	20
6	Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development Nature ·Xindong Liu, Xin Chen, Bo Zhong, Aibo Wang, Xiaohu Wang, Fuliang Chu, Roza Nurieva, Xiaowei Yan, Ping Chen, Laurens G. van der Flier, Hiroko Nakatsukasa, Sattva S. Neelapu, Wanjun Chen, Hans Clevers, Qiang Tian, Hai Qi, Lai Wei, Chen Dong	2014	254
7	Anti-PD-1 antibodies for the treatment of B-cell lymphoma OncoImmunology ·Fuliang Chu, Sattva S. Neelapu	2014	5
8	Abstract 4094: Identification of co-inhibitory receptor expression on T cells from gastric cancer patients Cancer Research ·Наталия Сергеевна Смолякова, Fuliang Chu, Songbing He, Jing Yu, Sally A. Hunsucker, Tina Yang, Ming Zhang, Sisi Ye, Yafen Li, Bin Liu, Jinle Tang, Huimin Meng, Gangli An, Lin Yang	2014	1
9	Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions Nature Medicine ·Yeonseok Chung, Shinya Tanaka, Fuliang Chu, Roza Nurieva, Gustavo Martínez, Seema Rawal, Yi-Hong Wang, Hoyong Lim, Joseph M. Reynolds, Shinichi Nakagawa, Л А Телешева, Mohammid Jasim Kadhim, Sattva S. Neelapu, Chen Dong Hit paper breakdown →	2011	877
10	Crystal Structure of a Bony Fish β2-Microglobulin Journal of Biological Chemistry ·Weihong Chen, Feng Gao, Fuliang Chu, Jianhua Zhang, George F. Gao, Chun Xia	2010	25
11	The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Acts as a Dominant Immunogen Revealed by a Clustering Region of Novel Functionally and Structurally Defined Cytotoxic T‐Lymphocyte Epitopes The Journal of Infectious Diseases ·Jun Liu, Yeping Sun, Jianxun Qi, Fuliang Chu, Hao Wu, Feng Gao, Taisheng Li, Jinghua Yan, George F. Gao	2010	106
12	Crystallization and preliminary X-ray analysis of the V domain of human nectin-2 Acta Crystallographica Section F Structural Biology and Crystallization Communications ·Xiaomin Qian, Jianxun Qi, Fuliang Chu, Jun Liu, Qing Li, Jinghua Yan	2009	1
13	In Vitro and In Vivo Effects of CT-011, a Humanized Anti–PD-1 Monoclonal Antibody, in Combination with Rituximab against Human B-Cell Lymphomas. Blood ·Fuliang Chu, Myriam Foglietta, Hong Qin, Rakesh Sharma, Qing Yi, Helen Lacey, Rinat Rotem‐Yehudar, Sattva S. Neelapu	2009	2
14	Crystal Structure of Myeloid Cell Activating Receptor Leukocyte Ig-like Receptor A2 (LILRA2/ILT1/LIR-7) Domain Swapped Dimer: Molecular Basis for Its Non-binding to MHC Complexes Journal of Molecular Biology ·Yong Chen, Feng Gao, Fuliang Chu, Hao Peng, S. Dekker, Yiwei Liu, Po Tien, George F. Gao	2009	18
15	Expression, purification, crystallization and preliminary X-ray diffraction analysis of grass carp β₂-microglobulin Acta Crystallographica Section F Structural Biology and Crystallization Communications ·Weihong Chen, Fuliang Chu, Hao Peng, Ishfaq Nazir Butt, Jianxun Qi, Fan Jiang, Chun Xia, Feng Gao	2008	3
16	First Glimpse of the Peptide Presentation by Rhesus Macaque MHC Class I: Crystal Structures of Mamu-A01 Complexed with Two Immunogenic SIV Epitopes and Insights into CTL Escape The Journal of Immunology* ·Fuliang Chu, Zhiyong Lou, Yu Wai Chen, Yiwei Liu, Bin Gao, S. Dekker, Abdul Hamid Khan, John I. Bell, Zihe Rao, George F. Gao	2007	32
17	Stability engineering, biophysical, and biological characterization of the myeloid activating receptor immunoglobulin-like transcript 1 (ILT1/LIR-7/LILRA2) Protein Expression and Purification ·Yong Chen, Fuliang Chu, Feng Gao, Bin Zhou, George F. Gao	2007	15
18	Complex assembly, crystallization and preliminary X-ray crystallographic studies of rhesus macaque MHC Mamu-A01 complexed with an immunodominant SIV-Gag nonapeptide Acta Crystallographica Section F Structural Biology and Crystallization Communications* ·Fuliang Chu, Zhiyong Lou, Bin Gao, John I. Bell, Zihe Rao, George F. Gao	2005	12
19	Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase European Journal of Clinical Microbiology & Infectious Diseases ·Dawei Xu, Zhidong Zhang, Lei Jin, Fuliang Chu, Yujie Liu, Hui‐Fang Wang, Min Liu, Ewa Maj, D J Lee, George F. Gao, Fang Wang	2005	89
20	Cellular protein kinase C isozyme regulation by exogenously delivered physiological disulfides--implications of oxidative protein kinase C regulation to cancer prevention Carcinogenesis ·Fuliang Chu	2003	18

About Fuliang Chu

Fuliang Chu is a scholar working on Immunology, Oncology, Pathology and Forensic Medicine, Virology and Genetics, having authored 39 papers that have together received 2.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (12 papers), Lymphoma Diagnosis and Treatment (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), T-cell and B-cell Immunology (9 papers), Immunotherapy and Immune Responses (8 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Galectins and Cancer Biology (3 papers). The work is most often cited by research in Immunology (1.4k citations), Virology (70 citations), Oncology (386 citations), Infectious Diseases (214 citations) and Transplantation (31 citations). Fuliang Chu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Sattva S. Neelapu, Chen Dong, Roza Nurieva, Seema Rawal, Shinya Tanaka, Gustavo Martínez, Hoyong Lim, Joseph M. Reynolds, Yeonseok Chung and Yi-Hong Wang. Their work appears in journals such as Blood, The Journal of Immunology, OncoImmunology, Journal for ImmunoTherapy of Cancer and Hematological Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact